U.S. Markets close in 21 mins.

Johnson & Johnson (JNJ)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
133.119-2.101 (-1.554%)
As of 3:39PM EDT. Market open.
People also watch
Full screen
Previous Close135.220
Bid133.030 x 200
Ask133.040 x 500
Day's Range132.340 - 134.290
52 Week Range109.320 - 137.080
Avg. Volume5,349,389
Market Cap357.29B
PE Ratio (TTM)22.52
Earnings DateN/A
Dividend & Yield3.36 (2.50%)
Ex-Dividend Date2017-08-25
1y Target EstN/A
Trade prices are not sourced from all markets
  • Pfizer files suit against J&J over Remicade contracts
    Reuters16 minutes ago

    Pfizer files suit against J&J over Remicade contracts

    Pfizer said in the suit that J&J is offering discounts on its Remicade treatment in exchange for essentially excluding Pfizer's drug from insurance coverage, keeping it out of the hands of patients. J&J said in an e-mailed statement that the lawsuit was without merit and that the company is competing on value and price.

  • Barrons.com1 hour ago

    J&J: You Can Only Stretch That Valuation So Far

    Back in April, Barron’s recommended buying shares of Johnson & Johnson (JNJ), arguing that the shares sold off too sharply after its first-quarter earnings report. Since then, J&J’s stock has gained 9%. Today, Goldman Sachs’s Jami Rubin told investors to find the exit.

  • The Wall Street Journal1 hour ago

    [$$] Murky World of Drug Rebates Gets Airing in Lawsuit

    The closely guarded world of drug pricing is getting a public airing in a feud between two of the industry’s biggest companies. The attention drawn to rebates could hurt the profits of some very successful ...